These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16052048)

  • 1. [Effect of a combination of teveten and prestarium in patients with chronic heart failure].
    Gorgoshidze ML; Abashidze TB
    Georgian Med News; 2005 Jun; (123):18-21. PubMed ID: 16052048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of prestarium in the treatment of chronic cor pulmonale].
    Lutaĭ AV; Shutemova EA; Egorova LA; Bogatyreva NV; Khalezova MA; Efimova EG
    Ter Arkh; 2000; 72(9):60-3. PubMed ID: 11076421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of prestarium in patients with chronic heart failure].
    Abashidze TB; Lortkipanidze RM
    Georgian Med News; 2005 Dec; (129):54-7. PubMed ID: 16444031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].
    Ditiatkov AE; Tikhonov VA; Radzevich AE
    Probl Tuberk; 2001; (8):37-9. PubMed ID: 11767390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of perstarium on the systolic and diastolic functions of the myocardium in patients with chronic cardiac failure].
    Fomina IG; Georgadze ZO; Sinitsyna MG; Gaĭdamakina NE; Nagieva AZ; Matveev VV
    Klin Med (Mosk); 2001; 79(8):20-3. PubMed ID: 11588778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eprosartan (Teveten) offers new opportunities to prevent a second stroke.
    Cardiovasc J S Afr; 2005; 16(1):56. PubMed ID: 15778775
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of cardiac output in patients with severe heart failure by use of ACE-inhibitors combined with the AT1-antagonist eprosartan.
    Gremmler B; Kunert M; Schleiting H; Ulbricht LJ
    Eur J Heart Fail; 2000 Jun; 2(2):183-7. PubMed ID: 10856732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of melaxen in combined therapy of arterial hypertension in subjects occupied in assembly line production].
    Zamotaev IuN; Enikeev AKh; Kolomoets NM
    Klin Med (Mosk); 2009; 87(6):46-9. PubMed ID: 19670717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficiency of perstarium in the treatment of patients with chronic obstructive bronchitis and pulmonary hypertension].
    Buturov IV; Buturov SI; Verbitskiĭ ON; Guzun RG; Paraska VI
    Probl Tuberk Bolezn Legk; 2003; (11):26-9. PubMed ID: 14689794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new ACE inhibitor and two new angiotensin receptor blockers for hypertension.
    Med Lett Drugs Ther; 1999 Nov; 41(1065):105-6. PubMed ID: 10575416
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of melatonin for correction of sleep disturbances in assembly-line shift workers with arterial hypertension].
    Zamotaev IuN
    Klin Med (Mosk); 2012; 90(3):44-6. PubMed ID: 22690565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
    Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and hemodynamical efficacy of prestarium and its role in the treatment of chronic pulmonary heart].
    Korneĭchuk NN; Butorov IV; Verbitskiĭ ON; Butorova VG; Paraska VI
    Ter Arkh; 2003; 75(10):83-7. PubMed ID: 14669615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of combination therapy with preduktal and prestarium on the left ventricular function in the postinfarction period].
    Dzhindzholiia NR; Megreladze II
    Georgian Med News; 2008 Feb; (155):20-3. PubMed ID: 18401050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eprosartan in secondary prevention of stroke: the economic evidence.
    Wessels F
    Cardiovasc J Afr; 2007; 18(2):95-6. PubMed ID: 17497046
    [No Abstract]   [Full Text] [Related]  

  • 20. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.